Kintara Therapeutics (KTRA) Short Interest Ratio & Short Volume → A new way to collect income from stocks (From DTI) (Ad) Free KTRA Stock Alerts $0.14 0.00 (0.00%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media Kintara Therapeutics Short Interest DataCurrent Short Volume4,040,000 sharesPrevious Short Volume700,000 sharesChange Vs. Previous Month+477.14%Dollar Volume Sold Short$627,412.00Short Interest Ratio / Days to Cover0.3Last Record DateApril 30, 2024Outstanding Shares55,310,000 sharesPercentage of Shares Shorted7.30%Today's Trading Volume14,493,778 sharesAverage Trading Volume7,781,863 sharesToday's Volume Vs. Average186% Short Selling Kintara Therapeutics ? Sign up to receive the latest short interest report for Kintara Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatKTRA Short Interest Over TimeKTRA Days to Cover Over TimeKTRA Percentage of Float Shorted Over Time Ad DTIYou missed the class - here’s your second chanceIt’s time to start your Weekend Side Hustle Right now, some of the HARDEST working folks are getting destroyed by inflation. And that’s left folks looking anywhere they can to generate extra income to cover the bills. It’s almost impossible to keep up with the ever rising costs of living anymore…Click here and I’ll give you the details. Kintara Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20244,040,000 shares $627,412.00 +477.1%N/A0.3 $0.16 4/15/2024700,000 shares $77,070.00 +6.2%N/A0.1 $0.11 3/31/2024658,900 shares $68,525.60 -70.1%N/A0 $0.10 3/15/20242,200,000 shares $207,020.00 +0.5%N/A0.2 $0.09 2/29/20242,190,000 shares $234,330.00 +432.7%N/A0.2 $0.11 2/15/2024411,100 shares $44,028.81 +150.7%N/A0 $0.11 Get the Latest News and Ratings for KTRA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Kintara Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024164,000 shares $23,747.20 -59.7%5.0%0 $0.14 1/15/2024407,100 shares $56,953.29 +234.8%12.3%0.1 $0.14 12/31/2023121,600 shares $20,623.36 -60.4%3.7%0 $0.17 12/15/2023306,900 shares $60,766.20 -12.8%9.3%0.3 $0.20 11/30/2023352,000 shares $119,680.00 -34.6%10.9%0.5 $0.34 11/15/2023538,500 shares $189,228.90 +541.8%32.3%1.3 $0.35 10/31/202383,900 shares $62,664.91 +126.2%5.0%0.6 $0.75 10/15/202337,100 shares $127,253.00 +152.4%2.2%2.1 $3.43 9/30/202314,700 shares $59,388.00 +53.1%0.9%0.9 $4.04 9/15/20239,600 shares $39,936.00 -66.6%0.6%0.1 $4.16 8/31/202328,700 shares $130,585.00 +38.0%1.8%0.2 $4.55 8/15/202320,800 shares $68,640.00 -23.3%1.2%0.1 $3.30 7/31/202327,100 shares $120,866.00 -46.6%1.6%0.2 $4.46 7/15/202350,700 shares $235,248.00 -9.8%3.1%0.3 $4.64 6/30/202356,200 shares $226,486.00 +200.5%3.4%0.3 $4.03 6/15/202318,700 shares $70,125.00 -26.4%1.1%0.5 $3.75 5/31/202325,400 shares $81,534.00 +75.2%1.5%0.6 $3.21 5/15/202314,500 shares $43,500.00 +12.4%0.9%0.3 $3.00 4/30/202312,900 shares $35,733.00 -41.9%0.8%0.3 $2.77 4/15/202322,200 shares $63,025.80 -12.9%1.4%0.9 $2.84 3/31/202325,500 shares $89,989.50 +390.4%1.6%0.9 $3.53 3/15/20235,200 shares $17,108.00 -85.4%0.3%0.1 $3.29 2/28/202335,600 shares $177,644.00 +65.6%2.2%0.5 $4.99 2/15/202321,500 shares $130,075.00 +9.7%1.3%0.1 $6.05 1/31/202319,600 shares $123,480.00 -14.4%1.2%0.1 $6.30 1/15/202322,900 shares $162,819.00 -42.2%1.5%0.1 $7.11 12/30/202239,600 shares $272,844.00 -56.3%2.7%0.1 $6.89 12/15/202290,600 shares $834,426.00 -75.7%N/A0.2 $9.21 11/30/2022373,400 shares $2.50 million +614.0%N/A1 $6.70 11/15/202252,300 shares $208,154.00 -97.4%N/A0.9 $3.98 10/31/20222,040,000 shares $219,708.00 +196.3%N/A0.9 $0.11 10/15/2022688,400 shares $65,535.68 -16.8%N/A0.2 $0.10 9/30/2022827,000 shares $89,316.00 +2.2%N/A0.3 $0.11 9/15/2022808,900 shares $128,210.65 -11.3%N/A0.3 $0.16This consistently signaled gains of 453%... 610%... and even 1036%... (Ad)It doesn’t happen often, but occasionally, something completely unique comes across my radar. In this case, I’m talking about legal “Insider Trading”. Traders who have consistently signaled 453% … 610% .. and even 1036%... gains. And until now they have been doing it completely under the radar. In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade.Register for the imminent briefing here. KTRA Short Interest - Frequently Asked Questions What is Kintara Therapeutics' current short interest? Short interest is the volume of Kintara Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 4,040,000 shares of KTRA short. Learn More on Kintara Therapeutics' current short interest. Is Kintara Therapeutics' short interest increasing or decreasing? Kintara Therapeutics saw a increase in short interest in April. As of April 30th, there was short interest totaling 4,040,000 shares, an increase of 477.1% from the previous total of 700,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Kintara Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Kintara Therapeutics: Cingulate Inc. (0.20%), Kazia Therapeutics Limited (0.53%), Synaptogenix, Inc. (2.88%), NexImmune, Inc. (0.55%), Bright Minds Biosciences Inc. (2.57%), TFF Pharmaceuticals, Inc. (4.07%), TransCode Therapeutics, Inc. (2.29%), Artelo Biosciences, Inc. (0.15%), Protagenic Therapeutics, Inc. (0.26%), Sonnet BioTherapeutics Holdings, Inc. (14.40%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Kintara Therapeutics stock? Short selling KTRA is an investing strategy that aims to generate trading profit from Kintara Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Kintara Therapeutics? A short squeeze for Kintara Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of KTRA, which in turn drives the price of the stock up even further. How often is Kintara Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KTRA, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: CING Short Interest KZIA Short Interest SNPX Short Interest NEXI Short Interest DRUG Short Interest TFFP Short Interest RNAZ Short Interest ARTL Short Interest PTIX Short Interest SONN Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:KTRA) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressMost important medical advance in 100 yearsThe Oxford ClubUrgent Nvidia WarningAltimetryShocking $16T Elon Musk Crypto LeakCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingNext President (Not Trump. Not Biden.)The Freeport Society41 banks launch ‘crypto dollar’Stansberry ResearchWhat’s Really Next for America…Porter & Company